Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.

Saved in:

Bibliographic Details
Title:	Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
Authors:	Wagner, U¹, Marth, C², Largillier, R³, Kaern, J⁴, Brown, C⁵, Heywood, M⁶, Bonaventura, T⁷, Vergote, I⁸, Piccirillo, M C⁹, Fossati, R¹⁰, Gebski, V⁵, Lauraine, E P¹¹
Source:	British Journal of Cancer. 8/7/2012, Vol. 107 Issue 4, p588-591. 4p. 4 Charts, 1 Graph.
Database:	Academic Search Ultimate

Description
ISSN:	00070920
DOI:	10.1038/bjc.2012.307